DGUOK gene mutation causes hepato-encephalopathy form of mitochondrial DNA depletion syndrome: clinical diagnosis and treatment and prenatal diagnosis

doi:10.3877/cma.j.issn.1673-5250.2020.04.013

Objective

To investigate clinical characteristics and prenatal diagnostic value of hepato-encephalopathy form of mitochondrial DNA depletion syndrome (MDS) caused by missense mutation variant in DGUOK gene.

Methods

A infant with hepato-encephalopathy form of MDS who was diagnosed and hospitalized in People′s Hospital of Xinjiang Uygur Autonomous Region in January 2018 due to " persistent jaundice for 4 months + 19 days and abnormal liver function for 1 months+ 19 days" , was selected as research subject. The clinical data of this case of infant were retrospectively analyzed, including clinical diagnosis and treatment process, gene mutation characteristics, etc..The procedure followed in this study was consistent with World Medical Association Declaration of Helsinki revised in 2013. For the treatment and genetic testing of the child, the informed consent of guardians was given and signed.

Results

① Collection of medical history: this case of infant was a girl, G₅P₃, hospitalized in hospital at age of 4 months+ 20 days old. She developed jaundice on the second day after birth and lasted until 4 months+ 19 days old, accompanied with nystagmus and abnormal liver function. Her family history referred to 2 neonates with jaundice and unexplainable neonatal death. At the age of 4 months, this case of infant developed bronchopneumonia, hypoproteinemia and systemic edema. At the age of 5 months, she died of respiratory, circulatory, liver and other multiple organ failure. ②Genetic testing results: mitochondrial nuclear gene screening results of peripheral blood sample showed that she had homozygous mutation variant of exon 1: c. 130G>A (p. Glu44Lys) in DGUOK gene, which was known as missense mutation and a reported pathogenicity mutation variant. ③ Prenatal diagnosis results: mother of this case of hepato-encephalopathy form of MDS infant was pregnant again at 30 years old. Sanger sequencing of amniotic fluid cast off cells at 20 weeks of the pregnant woman showed exon 1: c. 130G>A (p.glu44lys) heterozygous mutation variant in DGUOK gene, and the fetus was free of MDS.

Conclusions

For children with unexplained liver disease, especially when multiple organs were involved or tyrosinemia was suspected, attention should be paid to the possibility of hepato-encephalopathy form of MDS, which can be clearly diagnosed through gene analysis. Prenatal diagnosis of fetus MDS could be made by gene analysis of amniotic fluid cast off cells of fetus.

Key words: Mitochondrial diseases, Deoxyguanosine kinase deficiency, DGUOK gene, Prenatal diagnosis, DNA, mitochondrial, Genetic testing, Infant

表1 本例患儿生后不同时间点的血清生化检查结果比较

检查项目	出生时	生后10 d	生后75 d	生后90 d	生后140 d	正常参考值
总胆红素(μmol/L)^a	210.9	257.0	65.0	71.8	111.4	5.1～19.0
直接胆红素(μmol/L)^a	18.4	35.0	44.0	53.0	73.0	1.7～6.8
间接胆红素(μmol/L)^a	192.5	222.0	20.0	26.0	37.0	0～12.0
丙氨酸转氨酶(IU/L)^a	45	38	32	56	33	0～40
天冬氨酸氨基转移梅(IU/L)^a	81	42	80	131	108	0～45
白蛋白(g/L)	19	24	28	23	40	38～54
甲胎蛋白(μg/L)^b	17.56	17.32	15.21	>20.00	>20.00	<20.00
尿素氮(μmol/L)	7.9	7.3	6.2	5.1	2.3	1.7～8.3
肌酐(μmol/L)	14	53	68	56	35	59～104
尿酸(μmol/L)	96	186	216	211	236	202～416
血糖(mmol/L)^b	2.35	4.00	2.70	3.63	1.54	4.11～6.05
血清Ca^2＋(mmol/L)	2.13	2.63	2.17	2.51	2.39	2.25～2.75
血清K^＋(mmol/L)	3.9	4.2	3.6	5.2	4.6	3.5～5.0
血清Na^＋(mmol/L)	139.0	142.5	138.6	142.0	136.0	136.0～145.0
血清Cl^-(mmol/L)	107.3	111.0	103.2	102.0	100.2	98.0～110.0
血氨(μmol/L)^a	89.3	87.0	93.2	84.0	95.0	18.0～72.0
乳酸(mmol/L)^a	4.95	5.75	5.90	4.90	4.50	0.50～2.20
丙酮酸(μmol/L)^a	138	142	135	152	143	30～100

表1 本例患儿生后不同时间点的血清生化检查结果比较

检查项目	出生时	生后10 d	生后75 d	生后90 d	生后140 d	正常参考值
总胆红素(μmol/L)^a	210.9	257.0	65.0	71.8	111.4	5.1～19.0
直接胆红素(μmol/L)^a	18.4	35.0	44.0	53.0	73.0	1.7～6.8
间接胆红素(μmol/L)^a	192.5	222.0	20.0	26.0	37.0	0～12.0
丙氨酸转氨酶(IU/L)^a	45	38	32	56	33	0～40
天冬氨酸氨基转移梅(IU/L)^a	81	42	80	131	108	0～45
白蛋白(g/L)	19	24	28	23	40	38～54
甲胎蛋白(μg/L)^b	17.56	17.32	15.21	>20.00	>20.00	<20.00
尿素氮(μmol/L)	7.9	7.3	6.2	5.1	2.3	1.7～8.3
肌酐(μmol/L)	14	53	68	56	35	59～104
尿酸(μmol/L)	96	186	216	211	236	202～416
血糖(mmol/L)^b	2.35	4.00	2.70	3.63	1.54	4.11～6.05
血清Ca^2＋(mmol/L)	2.13	2.63	2.17	2.51	2.39	2.25～2.75
血清K^＋(mmol/L)	3.9	4.2	3.6	5.2	4.6	3.5～5.0
血清Na^＋(mmol/L)	139.0	142.5	138.6	142.0	136.0	136.0～145.0
血清Cl^-(mmol/L)	107.3	111.0	103.2	102.0	100.2	98.0～110.0
血氨(μmol/L)^a	89.3	87.0	93.2	84.0	95.0	18.0～72.0
乳酸(mmol/L)^a	4.95	5.75	5.90	4.90	4.50	0.50～2.20
丙酮酸(μmol/L)^a	138	142	135	152	143	30～100

图1 本例脑肝型线粒体DNA耗竭综合征患儿(女性，4^＋个月龄)的外周血外显子捕获测序结果图[患儿DGUOK基因第1外显子c.130G>A(p.Glu44Lys)纯合突变]

图2 本例患儿母亲及其再次妊娠胎儿的DGUOK基因Sanger法测序图[红色箭头所示为母亲、胎儿均存在第1外显子c.130G>A(p.Glu44Lys)杂合突变]

[1]	Spinazzola A, Invernizzi F, Carrara F, et al. Clinical and molecular features of mitochondrial DNA depletion syndromes[J]. J Inherit Metab Dis, 2009, 32(2): 143-158. DOI: 10.1007/s10545-008-1038-z.
[2]	Hakonen AH, Isohanni P, Paetau A, et al. Recessive Twinkle mutations in early onset encephalopathy with mtDNA depletion[J]. Brain, 2007, 130(Pt 11): 3032-3040. DOI: 10.1093/brain/awm242.
[3]	Mandel H, Szargel R, Labay V, et al. The deoxyguanosine kinase gene is mutated in individuals with depleted hepatocerebral mitochondrial DNA[J]. Nat Genet, 2001, 29(3): 337-341. DOI: 10.1038/ng746.
[4]	Spinazzola A, Viscomi C, Fernandez-Vizarra E, et al. MPV17 encodes an inner mitochondrial membrane protein and is mutated in infantile hepatic mitochondrial DNA depletion[J]. Nat Genet, 2006, 38(5): 570-575. DOI: 10.1038/ng1765.
[5]	Ferrari G, Lamantea E, Donati A, et al. Infantile hepatocerebral syndromes associated with mutations in the mitochondrial DNA polymerase-gammaA[J]. Brain, 2005, 128(Pt 4): 723-731. DOI: 10.1093/brain/awh410.
[6]	刘志梅，方方，丁昌红，等. SUCLA2相关脑肌病型线粒体DNA耗竭综合征一例并文献复习[J]. 中华儿科杂志，2014, 52(11): 817-821. DOI: 10.3760/cma.j.issn.0578-1310.2014.11.005.
[7]	邓梅，林伟霞，郭丽，等. 线粒体DNA耗竭综合征1例临床特点和DGUOK基因突变分析[J]．中国当代儿科杂志，2016, 18(6): 545-550. DOI: 10.7499/j.issn.1008-8830.2016.06.015.
[8]	徐佳鑫，黄博杰，姜红，等. 线粒体DNA耗竭综合征研究进展[J]. 中华实用儿科临床杂志，2019, 34(4): 314-317. DOI: 10.3760/cma.j.issn.2095-428X.2019.04.019.
[9]	Sarzi E, Bourdon A, Chrétien D, et al. Mitochondrial DNA depletion is a prevalent cause of multiple respiratory chain deficiency in childhood[J]. J Pediatr, 2007, 150(5): 531-534. e5346. DOI: 10.1016/j.jpeds.2007.01.044.
[10]	Lee WS, Sokol RJ. Mitochondrial hepatopathies: advances in genetics, therapeutic approaches, and outcomes[J]. J Pediatr, 2013, 163(4): 942-948. DOI: 10.1016/j.jpeds.2013.05.036.
[11]	Al-Hussaini A, Faqeih E, El-Hattab AW, et al. Clinical and molecular characteristics of mitochondrial DNA depletion syndrome associated with neonatal cholestasis and liver failure[J]. J Pediatr, 2014, 164(3): 553-559. e92. DOI: 10.1016/j.jpeds.2013.10.082.
[12]	Dimmock DP, Dunn JK, Feigenbaum A, et al. Abnormal neurological features predict poor survival and should preclude liver transplantation in patients with deoxyguanosine kinase deficiency[J]. Liver Transpl, 2008, 14(10): 1480-1485. DOI: 10.1002/lt.21556.
[13]	Lee NC, Dimmock D, Hwu WL, et al. Simultaneous detection of mitochondrial DNA depletion and single-exon deletion in the deoxyguanosine gene using array-based comparative genomic hybridisation[J]. Arch Dis Child, 2009, 94(1): 55-58. DOI: 10.1136/adc.2008.139584.
[14]	Mandel H, Hartman C, Berkowitz D, et al. The hepatic mitochondrial DNA depletion syndrome: ultrastructural changes in liver biopsies[J]. Hepatology, 2001, 34(4 Pt 1): 776-784. DOI: 10.1053/jhep.2001.27664.
[15]	Labarthe F, Dobbelaere D, Devisme L, et al. Clinical, biochemical and morphological features of hepatocerebral syndrome with mitochondrial DNA depletion due to deoxyguanosine kinase deficiency[J]. J Hepatol, 2005, 43(2): 333-341. DOI: 10.1016/j.jhep.2005.03.023.
[16]	Mousson de Camaret B, Taanman JW, Padet S, et al. Kinetic properties of mutant deoxyguanosine kinase in a case of reversible hepatic mtDNA depletion[J]. Biochem J, 2007, 402(2): 377-385. DOI: 10.1042/BJ20060705.
[17]	Freisinger P, Fütterer N, Lankes E, et al. Hepatocerebral mitochondrial DNA depletion syndrome caused by deoxyguanosine kinase (DGUOK) mutations[J]. Arch Neurol, 2006, 63(8): 1129-1134. DOI: 10.1001/archneur.63.8.1129.
[18]	Saito K, Kimura N, Oda N, et al. Pyruvate therapy for mitochondrial DNA depletion syndrome[J]. Biochim Biophys Acta, 2012, 1820(5): 632-636. DOI: 10.1016/j.bbagen.2011.08.006.
[19]	Bulst S, Holinski-Feder E, Payne B, et al. In vitro supplementation with deoxynucleoside monophosphates rescues mitochondrial DNA depletion[J]. Mol Genet Metab, 2012, 107(1-2): 95-103. DOI: 10.1016/j.ymgme.2012.04.022.
[20]	Slama A, Giurgea I, Debrey D, et al. Deoxyguanosine kinase mutations and combined deficiencies of the mitochondrial respiratory chain in patients with hepatic involvement[J]. Mol Genet Metab, 2005, 86(4): 462-465. DOI: 10.1016/j.ymgme.2005.09.006.
[21]	Salviati L, Sacconi S, Mancuso M, et al. Mitochondrial DNA depletion and dGK gene mutations[J]. Ann Neurol, 2002, 52(3): 311-317. DOI: 10.1002/ana.10284.

[1]	Shuihua Yang, Guidan He, Guican Qin, Mengfeng Liang, Yanhe Luo, Xueqin Li, Juansong Tang. Echocardioimagedata characteristics of fetal isolated total anomalous pulmonary venous connection and application of high definition flow imaging and spatio-temporal image correlation[J]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2023, 20(10): 1061-1067.
[2]	Lei Liu, Xin Yang, Xiaohua Xu, Shengmou Lin, Chuqin Xiong, Lilu Nong, Zhenyu Dong, Shengli Li. Measurement of fetal prenasal thickness and nasal bone length as a screening tool for trisomy 21, 18, and 13 in the second trimester of pregancy[J]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2023, 20(05): 506-510.
[3]	Changsheng Lin, Jun Zhan, Xue Xiao. Genetic testing and precision molecular targeted therapy in diagnosis and treatment of epithelial ovarian caner[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2023, 19(05): 505-510.
[4]	Haoyuan Yang, Jie Gong, Qingwei Zou, Hang Ruan. Current research status on adverse pregnancy outcomes of maternal and infant in pregnant women with asthma[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2023, 19(05): 522-529.
[5]	Xiaoyan Dong, Qi Zhao, Jun Tang, Li Zhang, Xiaoyan Yang, Jiao Li. Clinical characteristics of neonates infected with the Omicron variant of severe acute respiratory syndrome coronavirus 2[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2023, 19(05): 595-603.
[6]	Zhengyun Hu, Jianwei Shi, Jianwei Shen, Bing Wang, Chunmiao Jiang, Chong Liu. Identification of hub genes associated with bronchopulmonary dysplasia in preterm infants based on machine learning[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2023, 19(04): 446-454.
[7]	Ying Yang, Yan Liu, Yangdan Wang. Neonatal tuberous sclerosis complex related epilepsy: a case report and literature review[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2023, 19(04): 464-472.
[8]	Xu Wei, Ge Zhang, Jinlin Wu. Monitoring and treatment of neonatal sepsis-induced coagulopathy[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2023, 19(04): 379-386.
[9]	Chao Xue, Ye Zhang, Ying Zhao, Jiancheng Han, Xiaoyan Gu, Lin Sun, Xiaowei Liu, Wei Song, Yihua He. Ultrasonographic characteristics and prognosis of fetal congenital absent pulmonary valve syndrome[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2023, 19(04): 410-418.
[10]	Lili Lou, Hanmin Liu. Current research status of susceptibility genes and epigenetics on childhood asthma[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2023, 19(03): 249-255.
[11]	Meicen Zhou, Hua Wang, Dezhi Mu. Vaccination timeliness in preterm infants: a review of literature[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2023, 19(03): 261-266.
[12]	Lichao Fan, Jinying Guo, Xin Chen. The significance of detection of wild-type RET and RET/PTC fusion gene for lymph node dissection in the central region of papillary thyroid carcinoma[J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2023, 17(06): 631-635.
[13]	Wenqun Wang. Clinical efficacy of lysine gluzinc granules in the treatment of persistent diarrhea in infants and young children[J]. Chinese Journal of Digestion and Medical Imageology(Electronic Edition), 2023, 13(04): 250-253.
[14]	Mingda Tian, Jun Wu, Huijuan Wang, Xin Zhang, Yuying Sha, Lin Chen, Binyang Zhao. Bone mineral density of infants and toddlers aged 0-3 years[J]. Chinese Journal of Clinicians(Electronic Edition), 2023, 17(06): 644-647.
[15]	Qi Di, Sanlin Li, Gaolei Zhang, Jiajie Cao, Yi Xiong, Jing Zhang, Hao Wang, Jing Liu, Gang Shen. Clinical effects of 595 nm pulsed dye laser/1064 nm neodymium-doped yttrium alummlum garnet dual wavelength laser combined with local injection of pingyangmycin in treatment of infantile hemangioma[J]. Chinese Journal of Clinicians(Electronic Edition), 2023, 17(04): 391-397.

Viewed

Full text

Abstract

Please choose a citation manager

Content to export